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ABSTRACT
Objectives: Objective of the study was to evaluate the depression, anxiety and perceived stress level in adolescent girls 
with diagnosed polycystic ovary syndrome (PCOS), as well as to assess their body and self-esteem and its impact on 
emotional status.  
Material and methods: In 27 adolescent girls with confirmed diagnosis of PCOS (study group) as well as 27 healthy, regularly 
menstruating, age and BMI matched girls (control group) Hospital Anxiety and Depression Scale (HADS), Perceived Stress 
Scale-10 (PSS-10), Rosenberg Self-Esteem Scale (RSES) and Body-Esteem Scale (BES) containing three subscales (sexual 
attractiveness, weight concern, physical condition) were performed.
Results: There were no significant differences between PCOS group and control group in depression and PSS-10 scores, 
but the anxiety score was significantly higher in control than in PCOS group (9.6 ± 3.0 vs 7.3 ± 3.9, p = 0.02). Moreover, 
in BES subscales’ scores there were no significant differences between the groups, whereas RSES score was significantly 
higher in PCOS group (25.0 ± 7.1 vs 28.3 ± 4.6, p = 0.04). In PCOS group anxiety score was related to PSS-10 score (r = 0.56, 
p = 0.005). Moreover, we found that obesity was negatively related to anxiety (rƴ = –0.4, p = 0.04), depression (rƴ = –0.48, 
p = 0.02), PSS-10 (rƴ = –0.59, p = 0.004) and physical condition scores (rƴ = –0.44, p = 0.04). In girls with PCOS the more severe 
depression the worse weight control (rƴ = –0.56, p = 0.04).
Conclusions: We conclude that in adolescent girls PCOS is not related to anxiety and depressive symptoms as well as poor 
self-esteem.
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INTRODUCTION
Polycystic ovary syndrome (PCOS) is one of the most 
common endocrinopathies in adult women, with charac-
teristic features of anovulation, clinical and biochemical 
hyperandrogenism. It is a chronic condition leading to the 
occurrence of many relevant concerns, such as fear of in-
fertility, obesity and its metabolic complications and finally 
unfeminine, unattractive appearance due to hirsutism, acne 
or alopecia. PCOS begins in adolescent years, however in 
adolescent girls, clinical features of the syndrome could be 
less pronounced or be on the border with adolescent physi-
ology. Nevertheless, in adolescents, quality of life seems to 
be affected by similar signs and symptoms of PCOS as in 
adult women: excessive weight, clinical hyperandrogenism, 
menstrual disturbances and infertility [1].
There are many studies on psychological well-being, 
emotional problems and stress that arose from clinical fea-
tures, comorbidities and consequences of PCOS in adult 
women [2, 3]. Cooney et al. [2] in a meta-analysis showed 
that women with PCOS have significantly higher risk of 
moderate and severe depressive and anxiety symptoms, 
independently of obesity. Moreover, in women with PCOS 
increased risk of conversion to depression with time is ob-
served [3]. Their perceived stress in higher that in healthy 
women. The concerns about the emotional status led to 
recommendation for screening for depression and anxiety 
in all PCOS women, contained in guidelines of the assess-
ment and management of PCOS published by the Androgen 
Excess and PCOS Society [4]. 
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In today’s culture physical attractiveness is believed 
to be one of the main determinants of the success and 
physical features characteristic for PCOS, such as exces-
sive body weight, hirsutism and acne, are remote from the 
beauty standards [5]. They can lead to dissatisfaction with 
the appearance and lower self-esteem. In adult women 
PCOS is related to greater body dissatisfaction [6]. Moreover 
Bazarganipour et al., [7] shoved that PCOS women with 
amenorrhea had lover level of self-esteem and infertility was 
negatively associated with both self-esteem and body sat-
isfaction. Also in adolescents some researches showed that 
visible symptoms of androgen excess influence self-esteem 
and provoke discomfort [8]. 
The data about the psychological well-being of adoles-
cent girls with PCOS are less numerous, inconsistent and 
sometimes even conflicting. Considering the duration of 
the disease, the severity and type of the symptoms, as well 
as the specificity of lifetime period, the psychological and 
emotional consequences could be different than in adult 
patients, associated with different factors. The aim of the 
study was to evaluate the depression, anxiety and perceived 
stress level in adolescent girls with diagnosed PCOS, as well 
as to assess their body and self-esteem and its impact on 
emotional status.  
MATERIAL AND METHODS
We recruited 54 adolescent girls admitted to the De-
partment of Pediatric Endocrinology due to suspicion of 
hirsutism and/or menstrual disturbances. Twenty-seven 
adolescent girls with confirmed diagnosis of PCOS, prior to 
treatment introduction, were included into the study group 
and 27 healthy, regularly menstruating, non-hirsute, age 
and BMI matched girls who voluntarily agreed to partici-
pate into the study were included into the control group. 
PCOS was diagnosed according to the criteria proposed by 
Ibanez et al [9]. A diagnosis of PCOS was made when both 
criteria were present: menstrual disturbances (oligomen-
orrhea, secondary amenorrhea) and clinical or biochemi-
cal hyperandrogenism. Oligomenorrhea was defined as 
menstrual cycles longer than 45 days in the last six months 
(or less than 6 menstrual cycles during the last year) and 
secondary amenorrhea as a lack of menstruation in the 
last three months. Hirsutism, diagnosed if the modified 
Ferriman-Gallwey score was ≥ 8, was considered as a sign of 
clinical hyperandrogenism. Biochemical hyperandrogenism 
was identified by testosterone level ≥ 55 ng/mL [10]. The ex-
clusion criteria were other hormonal disturbances (abnormal 
thyroid function, hyperprolactinaemia, congenital adrenal 
hyperplasia) and former serious psychiatric disease.
The study was conducted according to Helsinki decla-
ration and approved by the Ethic Committee of The Medi-
cal University of Silesia (KNW/0022/KB1/79/12). Informed 
consent was obtained from each participant and their par-
ent/guardian.
In all participants somatic development data (weight, 
height) were measured, hirsutism score was assessed by the 
same observer (AZ). BMI was calculated and obesity was 
diagnosed in participants with BMI exceeded 97th percen-
tile. Serum level of androstenedione (A), testosterone (T), 
17-hydroxyprogesterone (17OHP), dehydroepiandros-
terone-sulfate (DHEAS) and estradiol (E2) were measured 
during follicular phase of menstrual cycle (2–5 day of the 
cycle) or after 3 months from last menstruation. Serum levels 
of T, DHEAS, and E2 were measured using chemiluminescent 
immunoassay by Immulite 2000 analyzer (DPC, USA). 17OHP 
and A were measured by enzyme-linked immunosorbent 
assay (DRG Diagnostics GmbH, Germany). 
Psychological assessment
Hospital Anxiety and Depression Scale (HADS), Per-
ceived Stress Scale-10 (PSS-10), Rosenberg Self-Esteem 
Scale (RSES) and Body-Esteem Scale (BES) were performed 
in all patients and controls. The questionnaires were anony-
mous and independently answered during unlimited time. 
The average time of completion was about 20 minutes. 
HADS is a questionnaire validated for Polish adolescents, 
consisted with seven questions dedicated to the assessment 
of anxiety, and seven to assess depression symptoms [11]. 
Scores of 8 or above are considered abnormal, characteristic 
for mild (score of 8-10), moderate (score of 11–14) and severe 
(score above 15) anxiety/depression symptoms.
PSS-10 is a questionnaire consisting of 10 items measur-
ing the perception of stress in the last month, developed by 
Cohen et al. in 1983 year [12], validated for Polish population 
by Juczynski and Oginska-Bulik [13]. It measures the degree 
to which situation in one’s life are appraised as stressful.
RSES is diagnostic 10-item tool assessing global 
self-worth, developed by Rosenberg in 1965 year. It uses 
four grade Likert scale from strongly agree to strongly disa-
gree [14]. 
BES is 35-item questionnaire assessing the body image 
in three subscales: 1) sexual attractiveness — related to 
the body parts those which appearance cannot generally 
be changed through exercise but only through cosmetics; 
2) weight concern — related to body parts that can be 
physically altered through exercise or control of food intake; 
3) physical condition — related to stamina, strength and 
agility. It was developed by Franzoi and Shields in 1984 year 
and validated for Polish population by Lipowska and Lip-
owski [15, 16]. It uses 5-point Likert scale where 1 means 
“I have strong negative feelings” and 5 — “I have strong 
positive feelings”.
The statistical analysis was performed using Statistica 
12,0 PL. The quantitative variables were described with 
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mean (SD) and qualitative variables were defined by fre-
quency (%). To evaluate the normality of variables Shap-
iro-Wilk test was used. We used χ2 test for qualitative data 
comparison of groups, and independent sample t-Student 
test and U Mann-Whitney test for quantitative data com-
parison of groups, as appropriate. Correlation analysis was 
performed using Pearson correlation coefficient for normally 
distributed samples, Spearman correlation coefficient for 
non-normally distributed data, and Gamma correlation for 
non-normally distributed data with many tide ranks. P val-
ue < 0.05 was considered statistically significant. To evaluate 
variables effecting the strength of the HADS scales, standard 
multiple regression analysis was performed with β coef-
ficient interpretation regarding the strength and direction 
of the relationship between variables.  
RESULTS
Twenty-seven adolescent girls with PCOS aged 13.6–
–17.9 years, as well as 27 healthy, regularly menstruated 
girls aged 14.3–18.0 years were involved into the study. 
The groups were age and BMI matched so the chronologi-
cal age, BMI and BMI z-score did not differ significantly 
between the groups. Clinical and hormonal characteristics 
are presented in Table 1. The menstrual disturbances were 
present in all girls from the study group and in all girls from 
the control group the menstrual cycles were regular. Obesity 
was seen in nine girls from the study group (33.3%) and 
13 from the control group (48%) (p = 0.2). The biochemical 
and/or clinical hyperandrogenism were present in all girls 
from the study group. Hirsutism was present in 10 subjects 
with PCOS (38.5%). However, most of the girls presented 
mild hirsutism (8–15 points in Ferriman-Gallwey scale) and 
only in one girl the excessive hair growth was assessed at 
16 points. Biochemical hyperandrogenism was found signifi-
cantly more often in girls from the study group than from the 
control group [15 girls (57.7%) vs 5 girls (23.8%), p = 0.02]. 
There were no significant differences in the depression 
score and PSS-10 score between the groups (p > 0.05) (Tab. 2). 
But anxiety score was significantly higher in the control 
group than in study group (p = 0.02). Moderate and severe 
anxiety was found in five (18.5%) girls with PCOS and in 
14 (51.8%) girls from the control group (p = 0.01), whereas 
moderate and high depression was present in one girl from 
the study group (3.7%) and in two girls from the control 
group (7.2%) (p > 0.05) (Fig. 1). There were no significant 
differences between PCOS and the control group for all sub-
scales of BES. Whereas RSES score was significantly higher 
in PCOS than in the control group (p = 0.04). 
In the study group we found significant positive cor-
relation between anxiety score and PSS-10 score (r = 0.56, 
p = 0.005) and negative with RSES score (r = –0.44, p = 0.03). 
PSS-10 score correlated negatively with RSES score (r = –0.58, 
p = 0.003). Surprisingly, depression score and PSS-10 score 
correlated negatively with BMI (r = –0.38, p = 0.049; r = –0.43, 
p = 0.03, respectively), whereas RSES score correlated posi-
tively with BMI (r = 0.53, p = 0.004). In the study group 
obesity was negatively related to anxiety score (rƴ = –0.4, 
p = 0.04), depression score (rƴ = –0.48, p = 0.02) and PSS-10 
score (rƴ = –0.59, p = 0.004) as well as physical condition 
score (rƴ = –0.44, p = 0.04). Moreover, we found that the 
more severe depression, the worse weight control (rƴ = –0.56, Table 1. Clinical and hormonal characteristics of adolescent girls with 
polycystic ovary syndrome (PCOS) and control group of healthy girls 
Girls with 
PCOS (n = 27)
Control 
group (n = 27) p
Chronological age 
[years] 16.7 ± 1.2 16.1 ± 1.1 NS
Gynaecological age 
[months] 52.5 ± 19.4 40.7 ± 16.9 NS
Cycle duration [days] 108.6 ± 60.8 29.7 ± 4.8 < 0.001
BMI z-score 1.1 ± 0.9 1.0 ± 1.0 NS
Ferriman-Gallwey 
score 5.2 ± 4.4 3.3 ± 2.9 NS
Testosterone [ng/dL] 61.2 ± 23.2 45.0 ± 14.2 0.009
Androstenedione 
[ng/mL] 4.6 ± 1.3 3.3 ± 0.8 < 0.001
DHEAS [µg/dL] 312.7 ± 134.5 266.2 ± 88.0 NS
17OHprogesteron 
[ng/mL] 2.4 ± 1.5 2.4 ± 1.8 NS
Estradiol [pmol/L] 155.0 ± 56.0 107.0 ± 80.4 0.052
PCOS — polycystic ovary syndrome; BMI — body mass index; DHEAS 
— dehydroepiandrosterone-sulfate; NS — nonsignificant
Table 2. Psychological assessment of adolescent girls with polycystic 
ovary syndrome (PCOS) and control group of healthy girls 
Girls with 
PCOS (n = 27)
Control group 
(n = 27) p
Hospital Anxiety and Depression Scale
anxiety [scores] 7.3 ± 3.9 9.6 ± 3.0 0.02
depression [scores] 4.2 ± 2.9 5.1 ± 3.4 NS
Perceived Stress Scale 
— 10 [scores] 22.0 ± 3.4 22.7 ± 3.3 NS
Rosenberg Self-Esteem 
Scale [scores] 28.3 ± 4.6 25.0 ± 7.1 0.04
Body Self Esteem
sexual attractiveness 
[score] 44.3 ± 5.2 44.0 ± 9.6 NS
weight concern [score] 28.1 ± 8.0 25.3 ± 10.5 NS
physical condition [scores] 30.7 ± 5.2 30.0 ± 6.5 NS
PCOS — polycystic ovary syndrome; NS — nonsignificant
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p = 0.04). We found no significant relationship between 
depression, anxiety, PSS-10, RSES and BES subscales scores 
and clinical and biochemical hyperandrogenism, as well as 
severity of clinical phenotype of PCOS.  
In multiple regression analysis, PSS-10, RSES, sexual 
attractiveness, weight concern, physical condition scores, 
BMI, hirsutism scores were included in the analysis as scale 
variables. The anxiety score was significantly associated 
with the PSS-10 score (β = 0.33, p = 0.05) in the control 
group but not in the study group. In examining depression 
score we found significant association with weight concern 
score in the control group (β = 0.72, p = 0.01) but not in 
the study group.  
DISCUSSION
The study was designed to estimate the depression and 
anxiety occurrence in adolescent girls with PCOS as well as 
to assess their self-esteem. We tried to study the relationship 
of depression, anxiety and self-esteem with clinical and bio-
chemical features of hyperandrogenism. The anxiety score 
was higher in control than in PCOS group, but we did not find 
any differences between the groups in depression and PSS-
10 scores. Researches showed that there is significant rela-
tionship between depression and anxiety and PCOS in adult 
women [17, 18]. The prevalence of depression and anxiety 
symptoms in women with PCOS is 29–50% and 57% respec-
tively [19, 20]. Moreover, the symptoms are related to hy-
perandrogenism, insulin resistance and in some research to 
obesity [20]. However, such relationships are not so obvious 
in adolescent girls with PCOS. The studies on psychological 
well-being in PCOS girls are on many fields scarce and con-
flicting. Quality of life in adolescent girls with PCOS by some 
researchers is assessed as negatively influenced by the 
syndrome [21], whereas in other studies no relationship 
was found [22]. Ghazeeni et al. [23], showed no significant 
difference with anxiety and depression status between 
the adolescent girls with PCOS and healthy age-matched 
girls. On the other hand, Eneksis et al. [24], found higher level 
of anxiety and depression in PCOS than in controls. How-
ever, their study group was older than our PCOS group, so 
the persistence of the clinical symptoms could last longer. 
And as showed Guidi et al. [25], significantly higher anxiety 
and depression, impaired well-being and quality of life was 
found among adolescents with hirsutism. However, in their 
research the hirsutism score was self-estimated, meaning 
strongly subjective assessment. Neither menstrual irregu-
larity, nor PCOS was associated with higher psychological 
distress. They concluded that among late adolescents and 
young women more important is concern about physical 
appearance then reproductive problems [25]. In our study 
we did not find the difference in depression score between 
the groups, whereas anxiety score was significantly higher 
in control group than in study group, significantly more 
girls from control group experienced moderate and severe 
anxiety. There could be several reasons underlying this lack 
of relationship. First, some symptoms of PCOS occurring 
during adolescence overlap findings that are considered 
physiological, normal during puberty [26]. Irregular menses 
occurring in many girls especially in the first years after men-
arche should not be treated as symptoms of PCOS, as well 
acne, which is typical physiological finding during puberty. 
So, these features could be perceived by adolescent girls 
as not pathological. Also, the main clinical presentation of 
hyperandrogenism, hirsutism could be mild in adolescent 
years, increases its severity with age. The severity of hirsut-
ism in studied girls with PCOS was also not very high, only 
in one girl from study group her excessive hair growth was 
assessed at more than 15 score in Ferriman-Gallwey scale. 
Most of the girls from the study group have mild hirsutism, 
which could be not very relevant to emotional distress. 
The reason for lack of anxiety and depression symptoms 
in our study group could be short duration of the symp-
toms, and there is also the suggestion that the predictor 
of the depression in women with PCOS is the age [26]. It is 
Figure 1. Distribution of no, low, average and high anxiety and depression symptoms in the study and control groups; Scores below 8 is 
characteristic for no anxiety/depression symptoms, 8–10 scores for mild, 11–14 score for moderate and > 15 score for severe anxiety/depression 
symptoms; HADS — Hospital Anxiety and Depression Scale
HADS anxiety
50
40
30
20
10
0
no low average high
control groupstudy group
no low average high
100
80
60
40
20
0
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postulated that not clinical hyperandrogenism per se but 
the chronic character of clinical features of PCOS could be 
associated with increased risk of depression and anxiety 
disturbances. In adult women the symptoms of menstrual 
irregularities and clinical hyperandrogenism last for many 
years with unsatisfactory results of treatment, leading to 
increase in emotional and psychological distress. And finally, 
very important concern which arises from the age and pe-
riod of life of young adult woman is infertility. 
The lack of difference between depression score with 
higher anxiety in control group could be also related to the 
control group characteristic. We involved into the control 
group adolescents with regular cycles without clinical hy-
perandrogenism, however they were referred to our clinic 
for evaluation due to a suspicion of hormonal disorders. 
All endocrine diseases were excluded in this group of girls 
however it seems that not real, objective physical signs 
of endocrine disturbances are important for the level of 
depression or anxiety but the subjective perception of the 
complains. Similar relationship we saw in our study group 
in respect to BMI. BMI correlated negatively with depres-
sion score and PSS-10 and positively with RSES, whereas 
more severe depression was related to the worse weight 
control. So, the issue is not a real weight status but how it 
is perceived. The similar depression score and lower anxiety 
could be related to the social and medical support that PCOS 
subjects get from the family and professionals as well from 
the fact that the cause of their symptoms was discovered. 
In the control group, with strong subjective beliefs of hor-
monal disturbances, the higher anxiety can be related to lack 
of symptoms interpretation despite of staying in hospital. 
The regression analysis, showing in the control group signifi-
cant influence of stress on anxiety score as well as weight con-
cern on depression score, seems to confirm these arguments. 
Body image is a mental picture of one’s body and it 
is highly subjective [7]. Usually, low self-esteem is associ-
ated with anxiety, depression, whereas high self-esteem 
may serve as a protection in coping with new or chronic 
disease [7]. In our study we also found significant negative 
relationship between anxiety and PSS-10 score and RSES 
score. However, the results about relationship of hyperan-
drogenism with self-esteem are conflicting [27]. According 
to Bazarganipour et al. [7] adult women with PCOS have 
poorer self-esteem and self-image satisfaction because 
of clinical symptoms as menstrual disorders, obesity and 
clinical hyperandrogenism (acne, alopecia, hirsutism). They 
found that women with PCOS with menstrual disorders had 
the greater body dissatisfaction, linking it especially with the 
fertility concern [7]. However, they examined women from 
Iran, where strong social pressure to have a child soon after 
marriage is present. In Poland, like in other European coun-
tries, there is a tendency to postpone the maternity. Accord-
ing to Eurostat, in recent years the average age of a Polish 
woman at the birth of the first child is 27.3 years [28]. So, the 
concern about fertility is also postpone in time. Keegan et 
al. [27] did not report the difference in self-esteem between 
women with and without hirsutism. In adolescents with 
PCOS, Coban et al. [22] showed no significant difference 
compared with control group. They also did not find any 
relationship between RSES score and clinical symptoms of 
hyperandrogenism [22]. In our study RSES score was even 
higher in PCOS group than in control one. Drosdzol et al. [29] 
showed that in adolescents with hirsutism RSES score was 
similar as in healthy peers. These results refer to RSES, which 
is very reliable but general tool that does not measure items 
of self-esteem related to physical appearance. That is why 
we decided to use also BES to assess body self-esteem in the 
three areas: sexual attractiveness, weight concern and physi-
cal condition. And we found also lack of significant differ-
ences in all three BES subscales scores between the groups, 
leading to the conclusion that the body self-esteem related 
to sexual attractiveness, weight concern and physical con-
dition is not influenced by PCOS in adolescent girls. To the 
similar conclusion arrived also Annagur et al., [30], finding 
that higher body satisfaction was present in PCOS women 
than in healthy control. 
Previous research suggested that excessive body weight 
gain during adolescence may be related to the depression, 
negative mood state and poor self-esteem [31]. Surprisingly, 
we found negative relationship between BMI and obesity 
and depression, anxiety and PSS-10 scores, meaning that 
the higher weight the lower level of depression, anxiety 
and perceived stress. It contrasts with other research in 
adults and adolescents [17, 18]. Moreover, RSES score sig-
nificantly correlated with BMI. However, in our previous 
research we showed that in adolescent girls with clinical 
hyperandrogenism and obesity, BMI z-score was positively 
related to social competences [32]. And the group with 
strongest inclinations to withdrawing from social relations 
was the non-hirsute, non-obese subgroup. It could be due 
to that excessive body weight is no longer the feature that 
stigmatize anybody, especially if the whole family is obese 
or overweight and increasing amounts of peers have exces-
sive body weight. Possible explanation is also the subjective, 
positive self-assessment of own body image which could 
neutralize negative self-assessment [33]. Obesity, lasting 
from early childhood could lead also to the feeling of “get-
ting used” to this image of the body, does not influence 
body self-esteem. The data about the influence of obesity 
on psychological distress are no so clear. In a meta-analysis, 
Rankin et al., [31] tried to clarify the relationship between 
excessive weight in children and depression and anxiety. 
They found that depression could be related to obesity in 
childhood, whereas the data about relation to anxiety disor-
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ders are not so obvious. However, study findings analyzed in 
this meta-analysis vary — in couple of them, obese children 
were found to be significantly more likely to experience 
depression. In other studies depression risk was only mod-
estly greater than in general population or the association 
was weak [31]. Moreover, three meta-analysis focusing on 
emotional distress and mental disorder in PCOS women 
suggested that BMI and hirsutism have a small or moderate 
effect on anxiety and depression [2, 34, 35]. 
CONCLUSIONS
We conclude that in adolescent girls PCOS is not re-
lated to anxiety and depressive symptoms as well as poor 
self-esteem. However, considering the possible relationship 
between PCOS and emotional distress in adult women, due 
to long lasting, chronic medical condition, patients with 
PCOS should be monitored for emotional and psychological 
problems from adolescence to adulthood. 
The study limitation is a relatively small number of re-
cruited patients. Increasing the size of the study group might 
demonstrate more reliable estimates for several independ-
ent variables as well determine the ability to detect further 
subtle relationships. 
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